Tag: hospice M&A

Chart showing key drivers that impact hospice EBITDA multiples, including compliance risk, earnings quality, and referral concentration.

Hospice Multiples in the Current Market: EBITDA Valuation Benchmarks, Methods, and What Drives the Multiple

December 30, 2025

Learn how hospice EBITDA multiples are set in today’s market—what drives the multiple, how compliance affects value, and how owners can prepare to maximize price.

Hospice M&A rebounds with strongest quarter since 2021, highlighting hospice valuation trends and buyer demand for quality agencies

Hospice M&A Rebounds: What the “Strongest Quarter Since 2021” Means for Hospice Owners Considering a Sale

December 27, 2025

Hospice M&A surged in late 2025, marking the strongest quarter since 2021. Learn what this means for hospice valuation, buyer demand, and selling strategy.